The transcription factor E2F mediates cell cycle-dependent expression of genes important for cell proliferation in response to growth stimulation. To further understand the role of E2F, we utilized a sensitive subtraction method to explore new E2F1 targets, which are expressed at low levels and might have been unrecognized in previous studies. We identified 33 new E2F1-inducible genes, including checkpoint genes Claspin and Rad51ap1, and four genes with unknown function required for cell cycle progression. Moreover, we found three groups of E2F1-inducible genes that were not induced by growth stimulation. At least, two groups of genes were directly induced by E2F1, indicating that E2F1 can regulate expression of genes not induced during the cell cycle. One included Neogenin, WASF1 and SGEF genes, which may have a role in differentiation or development. The other was the cyclin-dependent kinase inhibitor p27
Introduction
The E2F family of transcription factors plays a crucial role in the control of the cell cycle by coordinating the expression of genes involved in DNA replication and cell cycle progression (Nevins et al., 1997; Dyson, 1998; Trimarchi and Lees, 2002) . The transcriptional ability of E2F is cell cycle-regulated mainly through association with the retinoblastoma tumor suppressor family of proteins pRb, p107 and p130. During the progression of cells from G1 to S phase, G1 cyclin-dependent kinases (cdks) phosphorylate and dissociate the pRb family proteins from E2F, resulting in the activation of a group of genes required for progression into the S phase. Accordingly, expression of typical E2F target genes is growth-regulated in a cell cycle-dependent manner.
Apart from its role in cell cycle progression, E2F is thought to be involved in other biological processes. Deregulated E2F activity caused by the ectopic expression of E2F or by inactivation of pRb not only facilitates cell cycle progression but also induces apoptosis (Qin et al., 1994; Shan and Lee, 1994; Symonds et al., 1994; Wu and Levine, 1994; Kowalik et al., 1995) . The ectopic expression of E2F1 also causes cell cycle arrest under some cellular circumstance (Dimri et al., 2000) . In addition, recent efforts to explore downstream effectors of mammalian E2F using DNA microarrays and chromatin immunoprecipitation (ChIP) have identified a variety of putative E2F target genes. These targets are thought to be involved not only in cell cycle progression but also in apoptosis, checkpoints, DNA repair, metabolism, development and differentiation (Ishida et al., 2001; Muller et al., 2001; Polager et al., 2002; Ren et al., 2002; Weinmann et al., 2002; Cam et al., 2004) . However, the exact roles and regulatory mechanisms of E2F in biological processes other than cell cycle progression are yet to be elucidated. The induction of E2F targets involved in apoptosis or checkpoints during the cell cycle would interfere with normal cell growth and some of the genes could be differentially regulated from the cell cycle. Although E2F might be involved in the regulation of genes with a role in development and differentiation, whether such regulation is related to the cell cycle remains obscure.
Searching for genes induced by ectopic expression of E2F is a powerful technique to identify possible E2F targets, and it has been successfully used for DNA microarray experiments (Ishida et al., 2001; Muller et al., 2001; Polager et al., 2002) . However, microarrays have some disadvantages. First, the sensitivity is rather low compared with Northern blotting, raising the possibility that E2F targets expressed at low levels are left unidentified. Second, microarrays cannot detect unknown transcripts or discriminate variant transcripts from previously characterized transcripts.
To facilitate understanding the roles of mammalian E2F, we attempted to identify new E2F-inducible genes that are expressed at low levels and might remain unrecognized by previous microarray experiments. To this end, we used an improved subtraction method (Balzer and Baumlein, 1994) , which is sensitive to identify transcripts expressed at low levels. We used E2F1 among the E2F family members, since E2F1 could significantly change more genes than E2F2 and E2F3 when ectopically expressed (Muller et al., 2001) . Our analyses successfully identified new E2F1-inducible genes that were not detected in previous studies, including those with unknown function required for cell cycle progression. Moreover, we found E2F1-inducible genes with a distinct property from that of typical E2F targets. In contrast to general consensus that expression of typical E2F targets is growth-regulated, we found six transcripts, which are induced by E2F1 but not by serum stimulation. Analyses of these transcripts revealed three groups of genes with different characters. First included Neogenin, WASF1 and SGEF genes, which may have a role in differentiation or development. Second was the cdk inhibitor p27
Kip1 , an upstream regulator of the RB/E2F pathway. Third included variant transcripts of dysbindin and cyclin A2. At least, first and second groups of genes were directly induced by ectopic expression of E2F1 and were not induced during the cell cycle. These results indicate that there are groups of E2F1 targets, which are not induced during the cell cycle unlike typical E2F targets. Our results show that p27
Kip1 gene plays a role in suppression of inappropriate cell cycle progression induced by deregulated E2F, indicating biological significance of the distinct mode of E2F-mediated regulation of the gene.
Results
Sensitive subtraction screening for E2F1-inducible genes To identify genes induced by the ectopic expression of E2F1, we used an improved subtraction method combined with PCR amplification of cDNAs (Balzer and Baumlein, 1994) . E2F1 was ectopically expressed in serum-starved rat embryonic fibroblast REF52 cells by infecting a recombinant adenovirus expressing E2F1, and harvested for mRNA isolation at 21 h postinfection. Induction of a typical E2F target, Cdc6, and little effect on a p53 target, cyclin G1, were confirmed by Northern blotting (Figure 1a ). Double-stranded cDNAs were synthesized from E2F1-induced and control mRNAs, and subtraction was performed for three rounds according to the protocol (Figure 1b) . Enrichment of E2F1-inducible genes was confirmed by Southern blotting (Figure 1c) .
We analysed 2000 subtracted cDNA clones and identified 210 independent cDNA fragments. Among Novel E2F1 target genes R Iwanaga et al these, CDC2, DNA polymerase a, MCM5 and ribonucleotide reductase were known E2F targets. To confirm that the remaining 206 clones in fact represented E2F1-induced transcripts, we examined expression of all of the cDNAs by Northern blotting or by reverse transcription (RT)/PCR. Genes that were induced more than twofold by E2F1 were judged E2F1-inducible. The screening identified 40 genes including 27 known genes, 10 ESTs or cDNAs with unknown function and three unknown transcripts that were induced by E2F1 (Table 1) . Since expression of typical E2F targets is regulated by growth stimulation, we wanted to confirm whether these genes were induced by serum stimulation. Among the 40 E2F1-inducible genes, 34 genes were induced at 16 h after serum stimulation at least to some extent (Table 1) . Unexpectedly, however, the rest of six genes were not induced at all at this time point.
New E2F1-inducible genes induced by serum stimulation Among the 24 known genes induced by serum stimulation, only six genes (HisH3, Rad51, Ggh, Hey1, HMG2 and Ki-67) have been identified as E2F targets in previous DNA microarray or ChIP studies (Table 2 ) (Ishida et al., 2001; Muller et al., 2001; Polager et al., 2002; Ren et al., 2002; Weinmann et al., 2002) . Other 18 genes were newly identified in this study. Among these was the Claspin gene, which is notable because Claspin is the upstream regulator of the checkpoint kinase Chk1 (Kumagai and Dunphy, 2000) that can phosphorylate and activate p53 (Shieh et al., 2000) . This raises the possibility that the E2F1-induced expression of the Claspin gene might contribute, at least in part, to the induction of apoptosis by E2F1. We identified another checkpoint gene, Rad51-associated protein 1 (Rad51ap1), as well as previously identified Rad51. Since Claspin and Rad51ap1 were also induced by serum stimulation (Figure 2a ), we examined whether these genes were physiological targets of E2F. Kinetics studies after stimulating serum-starved REF52 cells with serum showed that the expression of both genes was growthregulated and induced around the G1/S boundary ( Figure 2b ). Reporter analyses showed that the promoters of both genes were activated by E2F1, E2F2 and E2F3, and by serum stimulation in serum-starved REF52 cells (Figure 2c ). E2F-like sites were found in both promoters and mutation of the sites raised basal activity under serum starvation and almost abolished responsiveness to the E2Fs and serum stimulation (Figure 2c ), indicating that activation of these promoters by serum stimulation is mainly mediated by E2F. Based on these results, we concluded that the Claspin and Rad51ap1 genes are physiological targets of E2F. We also identified new E2F1-inducible genes with roles in DNA replication, cell cycle progression, cellular metabolism, transcription, signal transduction and others as shown in Table 2 . These results are consistent with the recent reports and add new genes to these categories.
Among 10 ESTs or cDNAs with unknown function induced by serum stimulation, six genes (S25, S27-29, S31 and S32) had significant homology with mouse or human cDNAs with unknown function (Table 2 ). Since S26, S30 and S33 were homologous only to ESTs, and S34 was totally unknown, we identified the full-length cDNAs to obtain primary information. S26 cDNAs (S26-A and S26-B) were homologous to a mouse cDNA (AK029811) with unknown function (Figure 3a ). S30 cDNAs (S30-A and S30-B) were a homolog of mouse fidgetin-like 1 (Fignl1) (NM_021891), an AAA superfamily of ATPases (Figure 3b ). S33 cDNA (S33-D) contained the conserved domain for glycosyltransferase family 8, indicating involvement in lipopolysaccharide biosynthesis (Figure 3c ). S34 cDNAs (S34-A, S34-B and S34-C) were found to be new genes, which had homology only with a human EST (AA370083) and a mouse EST (BG077647) (Figure 3d ). The cDNAs were thought to be transcribed from 472 bp upstream of ubiquitin conjugating enzyme E2E3 gene in a bidirectionally divergent manner with one splicing event. Taken together, we identified Fignl1 and glycosyltransferaserelated gene, and eight cDNAs with unknown function as being inducible by both E2F1 and serum stimulation.
To investigate importance of the eight cDNAs with unknown function for cell cycle progression, we examined effect of knockdown of the gene expression by small hairpin (sh) RNA. ShRNA expression plasmids were constructed against four different regions of each of the cDNAs. REF52 cells were transfected with an shRNA expression vector for each of the cDNAs together with an EGFP expression vector, the cells were starved of serum, restimulated with serum, and then monitored for cell cycle progression in EGFP-positive cells at 18 h after serum stimulation. Significant decrease in S-G2M population was observed with S26, S28, S29 and S34, with at least two different shRNA constructs for each gene (Figure 3e ). These results suggest that expression of these genes is required for cell cycle progression, although involvement of S25, S27, S31 and S32 in E2F function other than cell cycle control cannot be excluded.
E2F1-inducible genes not induced by serum stimulation
Six cDNAs (Neogenin, WASF1, SGEF, E4, E5 and E6) were not induced at 16 h after serum stimulation (during S phase) (Table 3 ). These genes are not thought to be typical E2F targets, since typical E2F targets are induced by growth stimulation mostly at G1/S boundary of the cell cycle. We wished to examine the nature of these genes and the regulation by E2F. Numbers in parenthesis were identified by DNA microarray or ChIP elsewhere.
Novel E2F1 target genes R Iwanaga et al
Among the six genes, Neogenin, WASF1 and SGEF genes ( Figure 4a ) may have a role in differentiation or development (see Discussion). We first examined whether these genes were induced at other time points during the cell cycle. Kinetics study showed that expression of all of these genes was not induced by serum stimulation until 28 h (next G1 to S phases), indicating that these genes are not induced during the cell cycle after serum stimulation (Figure 4b and c). We thus examined whether the induction was the direct effect of E2F1. To this end, we used the estrogen receptor-E2F1 fusion (ER-E2F1) system, in which E2F1 can be activated in the absence of new protein synthesis (Muller et al., 2001) . A human osteosarcoma cell line U-2 OS cells stably expressing ER-E2F1 were incubated with 4-hydroxy tamoxifen (OHT) for 4 or 8 h in the presence or absence of cycloheximide (CHX) to inhibit protein synthesis, and expression of these genes was examined by Northern blotting. Expression of all of these genes was induced by adding OHT (Figure 4d ), Novel E2F1 target genes R Iwanaga et al indicating that induction of the genes by ectopically expressed E2F1 is conserved between rat and human. The levels of induction of Neogenin and SGEF genes were similar in the presence of CHX, indicating that the expression of the genes was directly induced by E2F1 (Figure 4d ). Although addition of CHX alone increased the level of WASF1 mRNA, early timing of the induction at 4 h by adding OHT strongly suggested that the induction is a direct effect of E2F1.
To further examine regulation of these genes by E2F, we analysed promoters of Neogenin and WASF1. 5 0 flanking sequences of these genes were linked to a (Figure 4e ), indicating that induction of these genes by E2F1 is mediated by activation of the promoters by E2F1. Experiments with 5 0 deletion mutants suggested that responsive regions to E2F1-mediated activation were located À565 to À383 and À288 to À95 for Neogenin, and À956 to À857 and À559 to À480 for WASF1. It is noteworthy that the location of responsive regions is more upstream than those of typical E2F targets, in which E2F-binding sites are located very close to transcriptional start sites. Moreover, there were no typical E2F-binding consensus sequence in the promoters used for the assay including these regions. These observations are consistent with the fact that these genes are not induced during the cell cycle unlike typical E2F targets. As direct effect of E2F1 on WASF1 gene was not definitive in ER-E2F1 system, we wanted to confirm the direct effect of E2F1 by examining whether ectopically expressed E2F1 binds to WASF1 promoter in vivo. HFFs were infected with recombinant adenovirus expressing E2F1 or control virus and binding of ectopically expressed E2F1 was examined by ChIP assay using primers flanking the À956 to À857 region of the WASF1 promoter. Significant binding of E2F1 was observed when E2F1 was overexpressed in HFFs (Figure 4f ), confirming that the induction is directly mediated by E2F1. Taken together, these results indicate that Neogenin, WASF1 and SGEF genes are direct targets of E2F1 that are not induced during the cell cycle.
p27
Kip1 gene is an atypical E2F target Among the rest of three E2F1-inducible genes not induced by serum stimulation, E4 (Figure 5a) showed identity only to a rat EST. To obtain primary information about E4 gene, we determined the fulllength cDNA. Unexpectedly, E4 cDNAs (E4-B and E4-C) showed identity to a rat p27
Kip1 cDNA (Figure 5b ), a member of the Cip/Kip family of cdk inhibitors. We confirmed regulation of the p27
Kip1 gene by E2F in HFFs. p27
Kip1 gene was induced 2.1-folds by E2F1 (Figure 5c ), whereas kinetics study showed rather decreased expression of the gene during the period when the MCM3 gene, a typical E2F target, was induced up to fivefolds (Figure 5d ). These results indicate that ectopic expression of E2F1 induces p27
Kip1 gene expression, which is not induced during the cell cycle after serum stimulation.
We next examined whether p27 Kip1 is induced by E2F1 at the level of protein expression in REF52 cells and HFFs by Western blotting. p27
Kip1 protein was induced by the ectopic expression of E2F1 in a dose-dependent manner (Figure 5e ). Induction of p27
Kip1 protein was dramatic as compared to induction at the mRNA level, suggesting that around two fold increase at mRNA level has significant impact on the protein expression, probably due to accumulation of the protein.
The induction of p27 Kip1 gene expression was also direct effect of E2F1 as examined by the ER-E2F1 system (Figure 5f ). We thus determined the effect of E2F1 on human p27
Kip1 promoter in serum-starved HFFs. The promoter activity was increased 2.4-folds by E2F1, but not by serum stimulation (Figure 5g , left panel), indicating that the induction of p27 Kip1 gene expression by E2F1 is mainly mediated by activation of p27 Kip1 promoter. The E2F1-responsive region was mapped to À814 to À635 by 5 0 deletion experiment (Figure 5g, right panel) . Binding of ectopically expressed E2F1 to p27 Kip1 promoter was demonstrated by ChIP assay using primers flanking the À814 to À635 region (Figure 5h ). Of note, these results indicate that the E2F responsive region is located far upstream than those of typical E2F targets. It should also be noted that the promoter used in the study does not contain typical E2F-binding consensus sequence. Collectively, these results indicate that the mode of transcriptional regulation of p27
Kip1 gene by E2F is dintinct from that of typical E2F targets. p27 Kip1 is known to be an upstream regulator of the RB/E2F pathway. However, our results suggest that p27
Kip1 can be a downstream target of the RB/E2F pathway upon deregulation of E2F. We wanted to examine the biological significance of the distinct regulation of p27 Kip1 gene by E2F. Ectopic expression of E2F1 is not sufficient to induce cell cycle progression in primary fibroblasts, and the ARF/p53/p21
Cip1 pathway and pRb play an important role in suppression of Sphase entry upon deregulation of E2F (Lomazzi et al., 2002) . In contrast, adenovirus E1a, which binds to and , we examined whether p27 Kip1 also plays a role in suppression of S-phase entry upon deregulation of E2F. For this purpose, we compared induction of DNA synthesis between in normal mouse embryonic fibroblasts (MEFs) and in p27À/À MEFs upon ectopic expression of E2F1 or adenovirus 12S E1a d2-11 mutant (Alevizopoulos et al., 1998) , which activates endogenous E2F by inactivating pRb family members but lacks p300-binding activity. The cells were made quiescent by starvation of serum, E2F1 or E1a d2-11 mutant was expressed by infecting recombinant adenoviruses, bromodeoxyuridine (BrdU) was added 4 h after infection of the virus and BrdU-positive cells were examined by FACS analysis at 20, 24 and 28 h after infection of the virus (Figure 5i) . Consistent with the previous report, E2F1 expression induced only a little increase in BrdU-positive cells both in wild-type MEFs and in p27À/À MEFs, whereas expression of the E1a Kip1 promoter in vivo. ChIP assay was performed as in Figure 4f .
(i) p27
Kip1 contributes to suppression of cell cycle progression upon pRb inactivation by E1a. Wild-type and p27À/À MEFs were serum starved for 3 days, infected with recombinant adenovirus expressing E2F1 or E1a d2-11 mutant, further cultured under serum starvation, BrdU was added at 4 h after infection, and harvested at the indicated time points for BrdU incorporation by FACS analysis. Percentages of BrdU-positive cells are indicated. 
Ectopic expression of E2F1 induces variant transcripts
Sequences of the rest of the two E2F1-inducible transcripts (E5 and E6) not induced by serum stimulation (Figure 6a ) did not match any known transcripts. To know the nature of the transcripts, we identified the full-length cDNAs with these sequences.
Two overlapping cDNAs (E5-A and E5-B) were obtained for E5 (Figure 6b) . Unexpectedly, the sequence had 91% identity to mouse dystrobrevin binding protein 1 (dysbindin) cDNA (BC018350). However, comparison of the rat cDNAs with the mouse genome revealed that the cDNAs were derived from sequences in intron 1 of the dysbindin gene spliced to exon 2 and downstream exons (Figure 6b ). The sequences of E5 fragment corresponded to those in intron 1. To confirm this, we discriminated E5 signal from that of dysbindin on Northern blot membranes using 20 mg of mRNAs. A signal was observed that was induced only by E2F1 with E5 fragment as a probe (Figure 6c, left panel) . When the same blot was stripped and reprobed with the rat dysbindin cDNA, an additional band appeared below the E5 signal (Figure 6c right panel) . The additional band was more intense and was not affected either by E2F1 or by serum stimulation. These results indicate that only the variant transcript of dysbindin was induced by E2F1.
Similarly, E6 cDNAs (E6-A and E6-B) were variant transcripts of cyclin A2 gene with the upstream sequences of exon 2 in intron 1 (Figure 6d ). In addition, E6-B contained extra sequences (nt 809-892) derived Novel E2F1 target genesfrom sequences in intron 2. The sequences of E6 fragment corresponded to those in intron 1. Owing to the presence of intronic sequences, the variant transcripts cannot encode previously characterized products of dysbindin or cyclin A2. We conclude that ectopic expression of E2F1 can induce variant transcripts of dysbindin and cyclin A2, which are not induced by serum stimulation.
Discussion
In the present study, by utilizing a sensitive subtraction method, we identified new E2F1-inducible genes, which may be difficult to be identified with microarrays due to their low level expression. These included checkpoint genes Claspin and Rad51ap1, and four genes with unknown function required for cell cycle progression. Moreover, in contrast to general consensus that expression of typical E2F targets is growth-regulated, we identified three groups of genes, which are induced by E2F1 but not by serum stimulation. At least, two groups of genes were directly induced by E2F1 and were not induced during the cell cycle, indicating that there are groups of E2F1 targets, which are not induced during the cell cycle. These included Neogenin, WASF1 and SGEF genes, which may have a role in differentiation or development, and the cdk inhibitor p27
Kip1
. Promoter analyses showed that E2F1-responsive regions of these genes were located more upstream than those of typical E2F targets and did not have typical E2F-binding consensus sequence. These results indicate that there is a distinct mode of E2F-mediated transcriptional control, in which E2F regulates expression of genes not induced during the cell cycle. Our results show that p27
Kip1 gene is involved in suppression of inappropriate cell cycle progression induced by deregulated E2F, indicating biological significance of the distinct mode of E2F-mediated regulation of the gene.
New E2F1 target genes induced by growth stimulation
Recent studies with microarray and ChIP identified a variety of possible E2F targets. However, whether many other targets, especially those expressed at low levels, are left unidentified is not known. We identified 40 E2F1-inducible genes by the sensitive subtraction method. It is noteworthy that only seven out of the 40 genes have been identified as E2F targets in previous studies and that all of the seven genes were known genes. Moreover, among the rest of the 20 known genes not previously identified, five genes (Adk, methylmalonyl co-enzyme A mutase, Dri 27/ZnT4, NCX1, Mapre1) were included in a previous DNA microarray experiment but remained undetected as E2F-inducible (Ishida et al., 2001) . These results indicate the possibility that many of E2F targets expressed at low levels remain undetected by microarrays and the number of E2F targets is much bigger than previously expected. Our results provide evidence that further analyses with different approaches such as the improved subtraction method is required to uncover whole aspects of E2F targets. In this regard, new E2F1-inducible genes identified in this study are valuable, since DNA microarrays may not be sensitive enough to identify these new targets.
Promoter analyses showed that the Claspin and Rad51ap1 genes are physiological targets of E2F. This suggests that the genes are induced by growth stimulation for checkpoint monitoring during S phase. Consistent with this notion, recent studies have shown that Claspin associates with chromatin during S phase (Lee et al., 2003) and is required for replication checkpoint control (Chini and Chen, 2003) . These results indicate that E2F is indeed involved in the regulation of the checkpoint gene expression during growth stimulation response.
We also identified eight cDNAs with unknown function as both E2F1-and serum-inducible. Expression of four out of the eight genes was required for cell cycle progression as examined by shRNA, suggesting important function of these gene products in cell cycle progression.
Cell cycle-independent E2F1 targets One prominent feature of transcriptional regulation by E2F is that the expression of typical targets is growthregulated in a cell cycle-dependent manner. In contrast to this notion, we identified three groups of E2F1-inducible genes, which were not induced by serum stimulation.
One group included variant transcripts of dysbindin and cyclin A2 genes with intronic sequences. Expression of both variant transcripts was detected in serumstarved and serum-stimulated cells without ectopic expression of E2F1 (Figure 6a and c) . In addition, searching GenBank identified four rat ESTs (AI029288, AI406852, AW915378 and CK473834), which contained the intronic sequences of the dysbindin variant transcripts. These observations indicate that the variant transcripts are expressed under physiological circumstances and were not generated by ectopic expression of E2F1. We do not know the physiological meaning of the expression of these variant transcripts at present. However, as the responsiveness is similar to other two groups and their expected functions are different from p27
Kip1 , it might be related to differentiation or development like Neogenin, WASF1 and SGEF (see below).
Other two groups of genes were directly induced by E2F1 and were not induced during the cell cycle, indicating that there are groups of E2F1 targets, which are not induced during the cell cycle. First group included Neogenin, WASF1 and SGEF. Neogenin is a cell surface protein induced in neural cells immediately before withdrawal from the cell cycle and terminal differentiation, suggesting involvement in the transition from cell proliferation to the terminal differentiation of specific cell types (Vielmetter et al., 1994) . WASF1 is a downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. It is predominantly expressed in the brain, suggesting a tissue-specific function (Nagase et al., 1996; Suetsugu et al., 1999) . SGEF is expressed in a rather wide range of adult tissues, but not in skeletal muscle or the immune and hemopoietic systems, suggesting a tissue-specific function (Qi et al., 2003) . The tissue-specific and developmental stage-specific expression of these genes suggests that they may have a role in differentiation or development. Our results indicate that at least some E2F targets with a role in differentiation and development is not induced during the cell cycle in fibroblasts unlike typical E2F targets.
Second group of E2F1 target not induced during the cell cycle was the cdk inhibitor p27
Kip1 , an upstream regulator of the RB/E2F pathway. Induction of the gene was also directly mediated by E2F1, indicating that p27
Kip1 can be a downstream effector of the RB/E2F pathway upon deregulation of E2F activity. Induction of p27
Kip1 gene by ectopic expression of E2F1 was reported very recently (Wang et al., 2005) . However, the point that the gene is not induced by growth stimulation was not revealed and thus the distinct mode of the regulation of p27
Kip1 gene by E2F has not been clarified in the study. Our results clearly indicate that the mode of the regulation of p27
Kip1 gene by E2F is distinct from that of typical E2F targets. First, the gene is activated by deregulated E2F, but not by E2F physiologically activated by serum stimulation. Second, the region responsible for the distinct regulation was mapped far upstream (À814 to À635) than that of typical E2F targets (mostly within À200 bp). Third, the region does not contain typical E2F-binding consensus sequence. In addition, deletion of the E2F-responsive region did not elevate the basal promoter activity unlike typical E2F-regulated promoters (data not shown), suggesting that the mode of regulation is activation and not release from repression by pRb family members. We also examined biological significance of regulation of p27
Kip1 gene by deregulated E2F activity. The results obtained from p27À/ÀMEFs show that, upon inactivation of pRb family by adenovirus E1a, p27
Kip1 gene is involved in suppression of inappropriate cell cycle progression induced by deregulated endogenous E2F activity. This is consistent with previous observations in Rb þ / Àp27À/À mice. Development of pituitary tumors in Rb þ /À mice correlates with reduced p27 mRNA and protein expressions, and was earlier in the Rb þ /Àp27À/ À mice than in Rb þ /À mice (Park et al., 1999) . Taken together, these observations suggest that the distinct mode of transcriptional regulation of p27
Kip1 gene by deregulated E2F functions as a checkpoint mechanism to prevent aberrant cell growth and underscores biological significance of the distinct regulation of the gene.
Materials and methods
Cell culture and infection with recombinant adenoviruses REF52 cells, HFFs, U2OS-ER-E2F1 (Muller et al., 2001) and MEFs were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS).
To synchronize the cell cycle, REF52 cells or HFFs cultured in DMEM with 0.1% FCS for 48 h or 72 h, respectively, were stimulated by adding a final concentration of 10% FCS. The recombinant adenovirus expressing human E2F1, Ad-E2F1 and the control virus, Ad-Con, have been described (Ohtani et al., 1998) . Ad-12SE1A(d2-11) was generated from CMV-E1A d2-11 mutant (Alevizopoulos et al., 1998) using ViraPower Adenoviral Expression System (Invitrogen) according to the manufacturer's protocol. The serum-starved cells were infected with the viruses at multiples of 200 plaque-forming units per cell in 2 ml per 150 mm plate for 1 h at 371C. The cells were further cultured in DMEM containing 0.1% FCS and harvested at the indicated time points.
Subtraction Subtraction was performed according to the improved gene expression screen (Balzer and Baumlein, 1994) . The E2F1-induced þ 6 cDNAs were cloned into pBluescript SK-(Stratagene) to generate a subtracted cDNA library.
Northern blotting
Northern blot analysis was performed as described (Ohtani et al., 1998) . Human acidic ribosomal phosphoprotein P0 (ARPP) cDNA was the control probe. Blots were exposed to an imaging plate (2040S) and analysed using an image analyser BAS 1500 (Fuji film).
Library screening cDNA libraries were constructed using mRNAs obtained from REF52 cells 16 h after serum stimulation or 21 h after infection with the E2F1 virus in lTriplEx2 (Clontech Laboratories). The libraries were screened by plaque hybridization according to standard procedures. The resultant clones were excised from the phages to generate pTriplEx2 plasmids and sequenced from both directions by primer walking.
Plasmids and reporter assay
Human Claspin and Rad51ap1 promoter-driven luciferase plasmids, pClaspin-Luc(-1055) and pRad51ap1-Luc(-1539), were generated by cloning À1055 to þ 75 (5 0 end of the cDNA (NM_022111) as þ 1) and À1539 to þ 51 (5 0 end of the cDNA (AF006259) as þ 1) regions into pGL3-Basic (Promega), respectively. pHsMCM5-Luc(-1384), pHsCdc6-Luc(-570), p27
Kip1 reporters pGL3-844-S, pGL3-635-S and pGL3-499-S, expression vectors for E2F1 through E2F3, and b-galactosidase expression vector pCMV-b-gal have been described (Ohtani et al., 1998 (Ohtani et al., , 1999 Ito et al., 1999) . pGL3-814-S and pGL3-788-S were generated by removing NheI-Bpu10I and NheI-ApaI region from pGL3-844-S, respectively. pNeogeninLuc(-1315) and pWASF1-Luc(-1165) were generated by cloning À1315 to þ 125 (5 0 end of the cDNA (NM_002499) as þ 1) and À1165-þ 81 (5 0 end of the cDNA (NM_003931) as þ 1) region into pGL3-Basic, respectively. 5 0 deletion mutants were generated using Deletion Kit for Kilo-sequencing (Takara). Transfection of REF52 cells and luciferase assays were performed as described (Ohtani et al., 1998) . HFFs were transfected with reporter and expression plasmids by lipofection using FuGENE 6 (Roche Diagnostics), together with pCMV-b-gal as an internal control. Luciferase activities were normalized to b-galactosidase activities. All assays were performed three times in duplicates and results are shown as means7s.d.
Western blotting
Western blot analysis proceeded as described (Iwanaga et al., 2001 ). Antibodies were anti-p27 Kip1 (1:500, sc-1641, Santa Cruz Biotechnology) and peroxidase-labeled anti-mouse IgG (1:5000, NA9310, Amersham Life Science). Proteins recognized by the antibodies were visualized using the enhanced chemiluminescence Western blotting detection system ECL þ (Amersham).
RNA interference
Target sequences for RNA interference against the new E2F1 targets were selected based on a published report (Elbashir et al., 2002) . ShRNA expression vectors were generated by inserting double-stranded oligonucleotides including the target sequences into the expression vector, pSilencer 2.0-U6 (Ambion), according to the manufacturer's protocol. Negative control was a random sequence and positive control was against GAPDH (Ambion).
ChIP assay
ChIP assay was performed as described (Takahashi et al., 2000) . Specific primer sets were, p27
Kip1
: 5 0 -GGCCTCCCCCG CAGACCAC-3 0 and 5 0 -GTTCCGCCACCTCCCCTCGTTCC-3 0 ; WASF1: 5 0 -GGAGTGGGCGGAGGCTGGATTTC-3 0 and 5 0 -GCTCACGCCTTACCCCTTCTTCAT-3 0 ; b-actin: 5 0 -GGTT TGCTCTTTGATGCTCTTGAT-3 0 and 5 0 -ACTTTCGGGT GGGGTGTAA-3 0 and Cdc6 as described (Takahashi et al., 2000) . Antibodies used for immunoprecipitating protein-DNA complexes were anti-E2F1 (sc-251 X) and anti-HA (sc-805) (Santa Cruz). Anti-HA antibody was a negative control. Input is one-twentieth of the reaction.
